New LC-MS/MS reference data for estradiol show mini-puberty in both sexes and typical pre-pubertal and pubertal patterns.

17β-estradiol LC-MS/MS immunoassay reference ranges

Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
23 Apr 2024
Historique:
received: 08 08 2023
revised: 19 12 2023
accepted: 01 02 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 23 4 2024
Statut: aheadofprint

Résumé

Reliable estradiol (E2) reference intervals (RIs) are crucial in Pediatric Endocrinology. To develop a sensitive ultra-performance liquid chromatographic tandem mass spectrometry (UPLC-MS/MS) method for E2 in serum, to establish graphically represented RI percentiles and annual RIs for both sexes and to perform a systematic literature comparison. First, an UPLC-MS/MS method for E2 was developed. Second, graphically represented RI percentiles and annual RIs covering 0-18 years were computed (cohort of healthy children (1181 girls, 543 boys)). Subsequently, RIs were compared with published data by systematic searches. Lower limit of quantification was 11 pmol/L, indicating high sensitivity. E2 first peaked during mini-puberty in both sexes (girls up to 192 pmol/L; boys up to: 225 pmol/L). As could be expected, girls showed higher pubertal E2 (up to 638 pmol/L). However, boys' RIs (up to 259 pmol/L) overlapped considerably. We found four studies in the literature which also used LC-MS/MS to determine E2 and published RIs for the complete pediatric age range. RIs varied considerably. Pre-pubertal and pubertal phases were present in all studies. Higher E2 during the time of mini-puberty in both sexes was documented in three studies including ours. Variability of RIs for E2 between studies illustrates importance of laboratory-specific RIs despite using a liquid chromatographic tandem mass spectrometry (LC-MS/MS) reference method. In boys, the striking E2 peak during mini-puberty as well as high pubertal E2 without phenotypic estrogenization in regular male puberty indicate that the role of E2 in children, and especially in boys requires better functional understanding.

Identifiants

pubmed: 38652605
pii: 7656846
doi: 10.1093/ejendo/lvae046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Endocrinology.

Auteurs

Alexandra E Kulle (AE)

Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine I, University Hospital of Schleswig - Holstein, Campus Kiel/Christian-Albrechts University of Kiel, Kiel, Germany.

Amke Caliebe (A)

Institute of Medical Informatics and Statistics, University Hospital of Schleswig - Holstein, Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany.

Tabea Lamprecht (T)

Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine I, University Hospital of Schleswig - Holstein, Campus Kiel/Christian-Albrechts University of Kiel, Kiel, Germany.

Thomas Reinehr (T)

Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine, Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Datteln, Germany.

Gunter Simic-Schleicher (G)

Children's Hospital of Bremen-Nord, Bremen, Germany.

Esther Schulz (E)

Pediatric Endocrinology, AKK Altonaer Kinderkrankenhaus GmbH, Hamburg, Germany.

Michaela Kleber (M)

MVZ Katholisches Klinikum gGmbH, children's hospital, department for children's endocrinology and diabetology, Bochum, Germany.

Juliane Rothermel (J)

MVZ Katholisches Klinikum gGmbH, children's hospital, department for children's endocrinology and diabetology, Bochum, Germany.

Sabine Heger (S)

Children's Hospital Auf der Bult, Hannover, Germany.

Olaf Hiort (O)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University-Hospital of Schleswig-Holstein, Campus Lübeck/University of Lübeck, Lübeck, Germany.

Paul-Martin Holterhus (PM)

Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine I, University Hospital of Schleswig - Holstein, Campus Kiel/Christian-Albrechts University of Kiel, Kiel, Germany.

Classifications MeSH